These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7783139)

  • 1. Receptor surface models. 1. Definition and construction.
    Hahn M
    J Med Chem; 1995 Jun; 38(12):2080-90. PubMed ID: 7783139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor surface models. 2. Application to quantitative structure-activity relationships studies.
    Hahn M; Rogers D
    J Med Chem; 1995 Jun; 38(12):2091-102. PubMed ID: 7783140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flexible docking using Tabu search and an empirical estimate of binding affinity.
    Baxter CA; Murray CW; Clark DE; Westhead DR; Eldridge MD
    Proteins; 1998 Nov; 33(3):367-82. PubMed ID: 9829696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving the quality of 3D-QSAR by using flexible-ligand receptor models.
    Pei J; Chen H; Liu Z; Han X; Wang Q; Shen B; Zhou J; Lai L
    J Chem Inf Model; 2005; 45(6):1920-33. PubMed ID: 16309299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atomistic modeling of enantioselective binding.
    Lipkowitz KB
    Acc Chem Res; 2000 Aug; 33(8):555-62. PubMed ID: 10955986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HostDesigner: a program for the de novo structure-based design of molecular receptors with binding sites that complement metal ion guests.
    Hay BP; Firman TK
    Inorg Chem; 2002 Oct; 41(21):5502-12. PubMed ID: 12377046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive models of protein-active sites.
    Walters DE
    Methods Mol Biol; 2000; 143():349-58. PubMed ID: 11084913
    [No Abstract]   [Full Text] [Related]  

  • 8. Determination of clefts in receptor structures.
    Lewis RA
    J Comput Aided Mol Des; 1989 Jun; 3(2):133-47. PubMed ID: 2550588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 3D model for the human hepatic asialoglycoprotein receptor (ASGP-R).
    Bianucci AM; Chiellini F
    J Biomol Struct Dyn; 2000 Dec; 18(3):435-51. PubMed ID: 11149519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-induced conformational changes: improved predictions of ligand binding conformations and affinities.
    Frimurer TM; Peters GH; Iversen LF; Andersen HS; Møller NP; Olsen OH
    Biophys J; 2003 Apr; 84(4):2273-81. PubMed ID: 12668436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The first supramolecular orthovanadate receptor -- structural mimics of vanadium haloperoxidase.
    Zhang XA; Meuwly M; Woggon WD
    J Inorg Biochem; 2004 Nov; 98(11):1967-70. PubMed ID: 15522422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a 3D model of the cannabinoid CB1 receptor: determination of helix ends and helix orientation.
    Bramblett RD; Panu AM; Ballesteros JA; Reggio PH
    Life Sci; 1995; 56(23-24):1971-82. PubMed ID: 7776821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor-drug association studies in the inhibition of the hematin aggregation process of malaria.
    Portela C; Afonso CM; Pinto MM; Ramos MJ
    FEBS Lett; 2003 Jul; 547(1-3):217-22. PubMed ID: 12860417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of simplified resiniferatoxin analogues with potent VR1 agonism elucidates an active conformation of RTX for VR1 binding.
    Lee J; Kim SY; Park S; Lim JO; Kim JM; Kang M; Lee J; Kang SU; Choi HK; Jin MK; Welter JD; Szabo T; Tran R; Pearce LV; Toth A; Blumberg PM
    Bioorg Med Chem; 2004 Mar; 12(5):1055-69. PubMed ID: 14980619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational drug design accommodating receptor flexibility: the relaxed complex scheme.
    Lin JH; Perryman AL; Schames JR; McCammon JA
    J Am Chem Soc; 2002 May; 124(20):5632-3. PubMed ID: 12010024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular modelling studies on the digitalis binding site of the Na+/K(+)-ATPase.
    Höltje HD; Anzali S
    Pharmazie; 1992 Sep; 47(9):691-7. PubMed ID: 1335579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Density functional theory calculations on entire proteins for free energies of binding: application to a model polar binding site.
    Fox SJ; Dziedzic J; Fox T; Tautermann CS; Skylaris CK
    Proteins; 2014 Dec; 82(12):3335-46. PubMed ID: 25212393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homology model of the CB1 cannabinoid receptor: sites critical for nonclassical cannabinoid agonist interaction.
    Shim JY; Welsh WJ; Howlett AC
    Biopolymers; 2003; 71(2):169-89. PubMed ID: 12767117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimode ligand binding in receptor site modeling: implementation in CoMFA.
    Lukacova V; Balaz S
    J Chem Inf Comput Sci; 2003; 43(6):2093-105. PubMed ID: 14632461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of biologically relevant conformations of anandamide, 2-arachidonylglycerol, and their analogues using conformational memories.
    Barnett-Norris J; Guarnieri F; Hurst DP; Reggio PH
    J Med Chem; 1998 Nov; 41(24):4861-72. PubMed ID: 9822555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.